Literature DB >> 11793454

Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations.

Till R Bader1, Richard C Semelka, Monica S Pedro, Diane M Armao, Mark A Brown, Paul L Molina.   

Abstract

PURPOSE: To determine the potential of a modified breath-hold 3D gradient-echo technique for visualizing pulmonary parenchymal diseases.
MATERIALS AND METHODS: Twenty-one magnetic resonance imaging (MRI) studies of the lungs were performed in 20 patients (15 male and 5 female; age range, 7.7-86.1 years) with pulmonary diseases comprising non-small-cell, small-cell, and bronchioalveolar carcinomas, endobronchial mucoepidermoid carcinoma, metastases, pneumonia, Wegener's granulomatosis, chronic obstructive pulmonary disease, arterio-venous malformation, and bronchogenic cyst. Confirmation of diagnoses was obtained via histopathology (14 patients) and follow-up (6 patients). MRI studies were performed at 1.5 T before and after administration of gadolinium using a modified volumetric interpolated breath-hold examination (VIBE) sequence. All images were evaluated prospectively regarding lesion detection and characterization. MR findings were correlated with final diagnoses. Retrospective grading (scores, 1-4) was performed for general image quality (rated "poor" to "excellent"); presence of artifacts ("negligible" to "severe"); and imaging quality of pulmonary lesions (conspicuity and contrast on pre- and postgadolinium images).
RESULTS: Twenty-three solid pulmonary lesions, 25 infiltrates and segmental atelectases, and 1 cyst were detected and prospectively correctly diagnosed. Sizes ranged from 0.3-10 cm. The mean scores for image quality and presence of artifacts were 3.3 (SD, 0.7) and 1.8 (SD, 0.7), respectively. Conspicuity and contrast of pulmonary lesions received mean scores between 3.0 and 3.8 (SD, 0.4-0.7).
CONCLUSION: This MRI technique allows imaging of a wide spectrum of solid and nonsolid pulmonary parenchymal diseases with reproducible high image quality, effective suppression of artifacts, high resolution, and visualization of gadolinium enhancement. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793454     DOI: 10.1002/jmri.10033

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  (1)H-MR imaging of the lungs at 3.0 T.

Authors:  Sergei I Obruchkov; Michael D Noseworthy
Journal:  Quant Imaging Med Surg       Date:  2016-02

2.  Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease.

Authors:  G Lutterbey; J Gieseke; M von Falkenhausen; N Morakkabati; H Schild
Journal:  Eur Radiol       Date:  2004-11-23       Impact factor: 5.315

3.  The Application and Value of 3T Magnetic Resonance Imaging in the Display of Pulmonary Nodules.

Authors:  Hui Feng; Gaofeng Shi; Hui Liu; Qian Xu; Lijia Wang; Ning Zhang
Journal:  Front Oncol       Date:  2022-05-18       Impact factor: 5.738

4.  Bias atlases for segmentation-based PET attenuation correction using PET-CT and MR.

Authors:  Jinsong Ouyang; Se Young Chun; Yoann Petibon; Ali A Bonab; Nathaniel Alpert; Georges El Fakhri
Journal:  IEEE Trans Nucl Sci       Date:  2013-10-01       Impact factor: 1.679

5.  Fetal MRI: A Technical Update with Educational Aspirations.

Authors:  Ali Gholipour; Judith A Estroff; Carol E Barnewolt; Richard L Robertson; P Ellen Grant; Borjan Gagoski; Simon K Warfield; Onur Afacan; Susan A Connolly; Jeffrey J Neil; Adam Wolfberg; Robert V Mulkern
Journal:  Concepts Magn Reson Part A Bridg Educ Res       Date:  2014-11       Impact factor: 0.481

6.  Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.

Authors:  Nina F Schwenzer; Ferdinand Seith; Sergios Gatidis; Cornelia Brendle; Holger Schmidt; Christina A Pfannenberg; Christian laFougère; Konstantin Nikolaou; Christina Schraml
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.